Biography

Dr Nabeemeeah has a keen interest in lung health and infectious diseases. She has more than 15 years of clinical experience and 10 years of research experience. She is the principal investigator of an ongoing TB vaccine clinical trial. She has also been an investigator on observational studies related to Tuberculosis and pneumococcal diseases.

Expertise

TB Diagnostics
Public Health

Key Impacts

Biomarkers for diabetes mellitus (DM) and inflammation in people diagnosed with pulmonary TB (PTB)

Fructosamine appeared to identify diabetes in people with TB. Dysglycaemia as identified by HbA1c was transitory and normalised post treatment.

Source: Conference 2024

Research Summaries